These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31563488)

  • 1. Distal Embolic Protection in Impella 5.0 Explantation: Loop and Snare Technique.
    Kawabori M; Pramil V; Shindgikar P; Zhan Y; Warner KG; Rastegar H; Kapur NK; Chen FY; Couper GS
    Ann Thorac Surg; 2020 Feb; 109(2):e145-e146. PubMed ID: 31563488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impella device for acute mechanical circulatory support in patients in cardiogenic shock.
    Lemaire A; Anderson MB; Lee LY; Scholz P; Prendergast T; Goodman A; Lozano AM; Spotnitz A; Batsides G
    Ann Thorac Surg; 2014 Jan; 97(1):133-8. PubMed ID: 24090575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term mechanical circulatory support with the Impella 5.0 device for cardiogenic shock at La Pitié-Salpêtrière.
    Mastroianni C; Bouabdallaoui N; Leprince P; Lebreton G
    Eur Heart J Acute Cardiovasc Care; 2017 Feb; 6(1):87-92. PubMed ID: 26873912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impella 5.5 Direct Aortic Implant and Explant Techniques.
    Anderson M; Smith D; Kane P; Lee R; Khalpey Z; Williams J
    Ann Thorac Surg; 2021 May; 111(5):e373-e375. PubMed ID: 33345787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-centre experience with the Impella CP, 5.0 and RP in 109 consecutive patients with profound cardiogenic shock.
    Jensen PB; Kann SH; Veien KT; Møller-Helgestad OK; Dahl JS; Rud CS; Jensen MK; Jensen LO; Schmidt H; Møller JE
    Eur Heart J Acute Cardiovasc Care; 2018 Feb; 7(1):53-61. PubMed ID: 29148290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impella support as a bridge to heart surgery in patients with cardiogenic shock.
    Saito S; Shibasaki I; Matsuoka T; Niitsuma K; Hirota S; Kanno Y; Kanazawa Y; Tezuka M; Takei Y; Tsuchiya G; Konishi T; Ogata K; Fukuda H
    Interact Cardiovasc Thorac Surg; 2022 Jul; 35(2):. PubMed ID: 35373286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thirty-five day Impella 5.0 support via right axillary side graft cannulation for acute cardiogenic shock.
    Castillo-Sang MA; Prasad SM; Singh J; Ewald GA; Silvestry SC
    Innovations (Phila); 2013; 8(4):307-9. PubMed ID: 24145977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-in-Man Percutaneous Transaxillary Artery Placement and Removal of the Impella 5.0 Mechanical Circulatory Support Device.
    Nakamura K; Krishnan S; Mahr C; McCabe JM
    J Invasive Cardiol; 2017 May; 29(5):E53-E59. PubMed ID: 28441642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of Impella 5.0 in Cardiogenic Shock: A Systematic Review and Meta-analysis.
    Batsides G; Massaro J; Cheung A; Soltesz E; Ramzy D; Anderson MB
    Innovations (Phila); 2018; 13(4):254-260. PubMed ID: 30142110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of Impella and mechanical devices in cardiogenic shock.
    Chera HH; Nagar M; Chang NL; Morales-Mangual C; Dous G; Marmur JD; Ihsan M; Madaj P; Rosen Y
    Expert Rev Med Devices; 2018 Apr; 15(4):293-299. PubMed ID: 29600725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: results of the Impella-EUROSHOCK-registry.
    Lauten A; Engström AE; Jung C; Empen K; Erne P; Cook S; Windecker S; Bergmann MW; Klingenberg R; Lüscher TF; Haude M; Rulands D; Butter C; Ullman B; Hellgren L; Modena MG; Pedrazzini G; Henriques JP; Figulla HR; Ferrari M
    Circ Heart Fail; 2013 Jan; 6(1):23-30. PubMed ID: 23212552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of the impella device for acute mechanical circulatory support.
    Lemaire A; Anderson MB; Prendergast T; Stockmaster N; Goodman A; Lozane AM; Batsides G
    Innovations (Phila); 2013; 8(1):12-6. PubMed ID: 23571788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and prognosis of vascular complications after percutaneous placement of left ventricular assist device.
    Abaunza M; Kabbani LS; Nypaver T; Greenbaum A; Balraj P; Qureshi S; Alqarqaz MA; Shepard AD
    J Vasc Surg; 2015 Aug; 62(2):417-23. PubMed ID: 26054591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced Percutaneous Mechanical Circulatory Support Devices for Cardiogenic Shock.
    Miller PE; Solomon MA; McAreavey D
    Crit Care Med; 2017 Nov; 45(11):1922-1929. PubMed ID: 28857849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanical circulatory support with the Impella 5.0 device for postcardiotomy cardiogenic shock: a three-center experience.
    Engström AE; Granfeldt H; Seybold-Epting W; Dahm M; Cocchieri R; Driessen AH; Sjauw KD; Vis MM; Baan J; Koch KT; De Jong M; Lagrand WK; Van Der Sloot JA; Tijssen JG; De Winter RJ; De Mol BA; Piek JJ; Henriques JP
    Minerva Cardioangiol; 2013 Oct; 61(5):539-46. PubMed ID: 24096248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Clinical Potential of Impella 5.0 Support in the Treatment of Recurrent Fulminant Viral Myocarditis with Profound Cardiogenic Shock.
    Ogawa S; Suzuki M; Ochi H; Saji M; Mahara K; Takamisawa I; Nishigawa K; Furuichi Y; Takanashi S; Isobe M
    Intern Med; 2019 May; 58(10):1459-1462. PubMed ID: 30626823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical transaxillary placement of the Impella 5.0 ventricular assist device.
    Bertoglio L; Katsarou M; Scandroglio M; Bertoldi L; Chiesa R; Pappalardo F
    J Card Surg; 2019 Feb; 34(2):92-98. PubMed ID: 30625252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bridging with surgically placed microaxial left ventricular assist devices: a high-volume centre experience.
    Gill G; Rowe G; Chen Q; Malas J; Thomas J; Peiris A; Cole R; Chikwe J; Megna D; Emerson D
    Eur J Cardiothorac Surg; 2023 Jun; 63(6):. PubMed ID: 36975609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of heart failure due to acute transplant rejection with the Impella LP 5.0.
    Samoukovic G; Al-Atassi T; Rosu C; Giannetti N; Cecere R
    Ann Thorac Surg; 2009 Jul; 88(1):271-3. PubMed ID: 19559242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secular Trend in the Use and Implementation of Impella in High-Risk Percutaneous Coronary Intervention and Cardiogenic Shock: A Real-World Experience.
    Hritani AW; Wani AS; Olet S; Lauterbach CJ; Allaqaband SQ; Bajwa T; Jan MF
    J Invasive Cardiol; 2019 Sep; 31(9):E265-E270. PubMed ID: 31478893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.